Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00068783
Status:
COMPLETED
Last Update Posted:
2013-02-28
First Post:
2003-09-10
Brief Title:
S0331 Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage III Neuroendocrine Carcinoma of the Skin |
| Recurrent Neuroendocrine Carcinoma of the Skin |
| Stage II Neuroendocrine Carcinoma of the Skin |
Keywords: